All News about Lexaria Bioscience Corp
Lexaria Announces 2023 Annual Meeting Results
May 10, 2023
Via ACCESSWIRE
Via Benzinga
Via Benzinga
Via Benzinga
Lexaria Bioscience Corp. (NASDAQ: LEXX), Featured in Recent Research Report by Zacks SCR
May 03, 2023
Topics
Bonds
Exposures
Debt Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|